You must report any side effects you experience to your doctor and healthcare team when on medications
The objective of the study was to demonstrate that orforglipron (3 mg, 12 mg, 36 mg) is superior in A1C reduction from baseline after 40 weeks, compared to placebo, in people with type 2 diabetes who have not taken any anti-diabetic medications for at least 90 days prior to visit 1, and are nave to insulin therapy
Before Retatrutide becomes available in the UK, it must complete several key steps
How to eat if your nausea makes you not hungry When nausea gets really bad, it can make it hard for you to eat food can become unappealing and you arent hungry
Because weekly injections allow flexibility, small timing adjustments rarely affect effectiveness
What the future of GLP-1s may look like An oral GLP-1 agonist might be a more attractive option